Skip to NavigationSkip to content

Pharmafile - Business Services News

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they...
Health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be...
There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according to a cross-party...
AstraZeneca’s Phase 3 THALES trial showed that Brilinta (ticagrelor) significantly reduced the rate of death or stroke in patients with acute...
The Sandoz division of Novartis will not make a profit on the 15 generics it is making available to developing nations to help them deal with the...
The Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention (CDC) and...
The government of Pakistan has decided to abolish all sections of the Drugs Pricing Policy, which will take away pharmaceutical companies' ability to...
Most people who test positive for COVID-19 do not have symptoms of the virus when tested, according to the Office of National Statistics (ONS).
Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s drug remdesivir, which is one of the...
Coronavirus immunity in the world’s population may be more widespread than initially thought, even in those who have tested negative for antibodies,...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches